TE_6821

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family L1HS_5end
TE superfamily L1
TE class LINE
Gene -
Class Intergenic
Coding Non-coding, Other
Tumor-specific score 220.23
Counts of samples TCGA_tumor:976; TCGA_normal:3; GTEx:1
TSS chr3(+):18936133



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_6821.21 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18966293,18966407,19075965,19076080,19078880,19078934,19126386,19126466,19127013,19127033
teRNA_6821.22 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18966293,18966407,19075965,19076080,19078880,19078934,19125733,19125805,19126386,19126466,19127013,19127033
teRNA_6821.23 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18966293,18966407,19012332,19012352
teRNA_6821.24 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18966293,18966407,19021376,19021503,19075965,19076080,19078880,19078934,19114239,19114259
teRNA_6821.25 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18966293,18966407,19021376,19021503,19075965,19076080,19078883,19078934,19125733,19125805,19126386,19126466,19127013,19127142,19143051,19143071
teRNA_6821.26 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18966293,18966407,19075965,19076080,19078883,19078934,19125733,19125805,19126386,19126406
teRNA_6821.27 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18966293,18966407,19075965,19076080,19078880,19078934,19114239,19114259
teRNA_6821.28 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18966293,18966407,19075965,19076080,19078883,19078934,19093246,19093266
teRNA_6821.29 - Intergenic Non-coding Non-coding chr3(+):18936134,18936522,18937724,18937744
teRNA_6821.30 - Intergenic Non-coding Non-coding chr3(+):18936134,18936522,18937724,18937805,18966293,18966407,19004638,19004658


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).